Navigation Links
Labopharm Reports Results for First Quarter Fiscal 2009
Date:5/7/2009

om $3.2 million for the first quarter of fiscal 2008. Revenue from sales of the Company's once-daily tramadol product for the first quarter of fiscal 2009 increased to $3.8 million from $2.2 million for the first quarter of fiscal 2008. Adjusted gross margin for the first quarter of fiscal 2009 was 57% compared with 58% for the first quarter of fiscal 2008. Research and development expenses, before research and development tax credits, for the first quarter of fiscal 2009 were $4.3 million compared with $6.9 million for the first quarter of fiscal 2008. Selling, general and administrative expenses for the first quarter of fiscal 2009 were $6.7 million compared with $4.9 million for the first quarter of fiscal 2008 and included an accrual of $0.7 million for the Company's share of litigation costs related to patent enforcement following approval of its once-daily tramadol product in the U.S. Net loss for the first quarter of fiscal 2009 was $8.0 million, or $0.14 per share, compared with $9.7 million, or $0.17 per share, for the first quarter of fiscal 2008.

    Recent Developments

    Once-Daily Tramadol

Product Ranked Number One in New-to-Brand Prescriptions in Canada - Labopharm's product (marketed under the brand name Tridural(TM) in Canada) ranked number one among tramadol products (excluding combination products) in terms of new-to-brand prescriptions in Canada for the first quarter of 2009. Market share for Labopharm's product among tramadol products (excluding combination products) in Canada for the same period was 36%. The number of prescriptions written for Labopharm's product in Canada for the first quarter of 2009 increased 19% compared to the fourth quarter of 2008.

In-Market Sales in Europe Continue to Grow - In-market sales of Labopharm's product in Europe(1) grew 9% for the first two months of 2009 compared to the same period of 2008. Sales to European marketing partners are continuing to p
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... , ... August 01, 2015 , ... On Tuesday, July ... , who are thought to have been behind the attack on Anthem Inc. which ... were zero day exploits, watering hole attacks and spear phishing campaigns. , ...
(Date:8/1/2015)... ... ... March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery ... off Springer Mountain and heading north. Since that day, Phil has hiked over 1400 miles ... by friends and family. He visited CCAR and left an inspirational message to his ...
(Date:7/31/2015)... (PRWEB) , ... August 01, 2015 , ... The Honor ... Global Advisory Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in San ... to participate in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently ... know in predictive health analytics , Jvion continues to disrupt the predictive ... predictive software that targets patient and population level illness to drive prevention and ...
(Date:7/31/2015)... ... ... There’s no better way to enjoy the summer weather than by being ... meal, making July the most appropriate to be National Hot Dog Month. King Kullen ... the next cookout different than the ones in the past. Celebrate National Hot Dog ...
Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... plays a surprising role reducing the level of infection caused ... cancer patients and others with weakened immune systems. The ... fungal evaders by enhancing the body,s ability to chew them ... where it would continue to provoke an onslaught of harmful ...
... August 19, 2010The first successful report of using cell-depleted lung ... from embryonic stem cells is presented in a breakthrough article ... published by Mary Ann Liebert, Inc. ( www.liebertpub.com ). The ... Embryonic stem cells (ESCs) have the potential to mature into ...
... doctoral student Lisa Carter-Harris has received the Johnson & ... Colleges of Nursing Minority Nursing Faculty Scholarship for the ... to graduate nursing students from minority backgrounds who agree ... , The AACN will hold $1,500 to cover expenses ...
... A recent study by researchers at Penn State College of ... lupus erythematosus (SLE) patients at the time of hospital admission ... women were youngest to both be admitted with CVD and ... the study appear in the September issue of Arthritis ...
... Reporter , WEDNESDAY, Aug. 18 (HealthDay News) -- Fibromyalgia sufferers ... tai chi, new research finds. Researchers divided 66 people ... of tai chi twice a week for 12 weeks; the ... stretching. At the end of 12 weeks, the ...
... A team of University of Michigan scientists has found ... roundworms. Scientists who study aging have long known that significantly ... is to find less drastic ways to achieve the same ... evidence that scientists may succeed at finding targets for drugs ...
Cached Medicine News:Health News:Old drug holds promise against opportunistic lung bug 2Health News:Old drug holds promise against opportunistic lung bug 3Health News:Old drug holds promise against opportunistic lung bug 4Health News:Natural lung material is promising scaffold for engineering lung tissue using embryonic stem cells 2Health News:UofL student wins national minority nursing scholarship 2Health News:Black women with SLE develop cardiovascular disease at early age 2Health News:Black women with SLE develop cardiovascular disease at early age 3Health News:Tai Chi May Help Ease Fibromyalgia 2Health News:Tai Chi May Help Ease Fibromyalgia 3Health News:Discovery may aid search for anti-aging drugs 2Health News:Discovery may aid search for anti-aging drugs 3
(Date:7/30/2015)... SAN DIEGO, July 30, 2015  ResMed Inc. (NYSE: ... ended June 30, 2015.  Revenue for the quarter was ... quarter ended June 30, 2014 (a 17 percent increase ... million, consistent with the quarter ended June 30, 2014. ... consistent with the quarter ended June 30, 2014.  ...
(Date:7/30/2015)... , July 30, 2015  Today we bring you a special edition of ... to remind you about some of our Medicare resources and continue highlighting the success ... Check out our latest infographics and videos here: ... ... ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19
... tells her story but sometimes showing a few less chapters ... quest continues for new ways to keep skin looking its ... survey commissioned by Ulthera ® (the manufacturer of the ... a non-invasive lift indication), 83 percent of women admitted they ...
... Boston Scientific Corporation (NYSE: BSX ) today ... the 60th Annual Scientific Session of the American College ... "Twelve-month results from the PLATINUM Workhorse clinical ... Element™ Everolimus-Eluting Platinum Chromium (PtCr) Stent as compared to ...
Cached Medicine Technology:What Would Women Give Up for a More Youthful Face? 2What Would Women Give Up for a More Youthful Face? 3Boston Scientific Announces Its ACC 2011 Schedule 2Boston Scientific Announces Its ACC 2011 Schedule 3Boston Scientific Announces Its ACC 2011 Schedule 4Boston Scientific Announces Its ACC 2011 Schedule 5Boston Scientific Announces Its ACC 2011 Schedule 6
... many patients with a diseased heart, the only therapy ... heart transplant. However, donor organs are not always readily ... they are on the waiting list for a donor ... can save the life of a patient. On the ...
... InstaTest AFP is an immunochromatographic in ... protein (AFP) in human serum. AFP is ... 67,000 to 74,000 D. Its normal concentration ... concentrations are associated with hepatoma and ovarian, ...
... STA Compact is a ... coagulation analyser for clotting, ... based .coagulation tests.The medium-throughput ... of primary tubes, 45 ...
... Our high-quality MPD Lancets are designed with ... the tri-bevel, thin gauge needle with its ... smoother, less painful penetration without tearing the ... body is easy to grip, even for ...
Medicine Products: